PT-141
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: PT-141 (Bremelanotide) is a synthetic cyclic peptide derived from Melanotan II, specifically developed to treat sexual dysfunction without inducing skin pigmentation.
How it works: Unlike PDE5 inhibitors (like Viagra) that only act locally on blood vessels in the genitals, PT-141 acts centrally in the brain. It crosses the blood-brain barrier to bind to Melanocortin-4 Receptors (MC4R) in the medial preoptic area and hypothalamus, activating natural neural pathways of sexual desire, arousal, and motivation in both men and women.
Why researchers study it: Clinically approved and studied for hypoactive sexual desire disorder (HSDD) in premenopausal women, refractory erectile dysfunction in men, and boosting sexual intimacy.
Compound & Molecular Specifications
Certificate of Analysis StandardsFrequently Stacked with PT-141 (Bremelanotide)
Clinically verified combinations activating complementary physiological pathways without receptor competition.
Melanotan II
Melanotan II provides systemic melanin upregulation via MC1R/MC4R, while PT-141 (Bremelanotide) selectively acts centrally on hypothalamic MC4R to trigger rapid erectile and sexual arousal pathways without cardiovascular vasoconstriction.
